Leveraging Mirimus RNAi technology, a study led by Tuebingen University shows that a new drug has the potential to revolutionize liver surgery and liver transplantation. NEW YORK, March 18, 2024 /PRNewswire-PRWeb/ -- Mirimus, a pioneer in RNAi therapeutic design and CRISPR/Cas9 gene...
↧
